Close
Novotech
Jabsco PureFlo 21 Single Use

Agility Receives WDA(H) Authorisation for Pharmaceuticals

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Integrated Inspection Systems for Leak Detection in Pharma

The pharmaceutical industry is increasingly moving toward a more holistic approach to quality control by combining various inspection technologies into a single, unified platform. Integrated inspection systems for leak detection in pharma offer a multi-faceted solution that simultaneously addresses cosmetic defects, particulate contamination, and container closure integrity. By merging high-speed visual cameras with sensitive high-voltage leak detection modules, these systems provide a comprehensive assessment of every unit, ensuring that each dose of medication is contained within a perfectly sealed and sterile environment. This integration not only reduces the risk of secondary contamination but also significantly improves the overall efficiency and reliability of the manufacturing process.

Advancing Pharma Quality with HV Leak Detection Tools

Maintaining the highest standards of pharmaceutical quality is a fundamental requirement for the safe delivery of injectable medications. The development of advancing pharma quality with HV leak detection tools represents a major leap forward in the deterministic testing of container closure integrity. By utilizing sophisticated sensors and high-voltage electrical fields, these tools can detect microscopic structural defects that would otherwise compromise the sterility of life-saving products. This high-sensitivity approach significantly enhances the accuracy of the inspection process, providing manufacturers with a robust solution for ensuring packaging integrity and regulatory compliance.
- Advertisement -

Agility, a leading global logistics provider, has received a Wholesaler Distribution Authorisation (for Medicines for Human Use) from the UK Medicines Healthcare & Regulatory Agency (MHRA).

The certification, referred to as WDA(H), authorizes warehousing and cross-dock of a wide range of pharmaceuticals, including finished products and active pharmaceutical ingredients (API) under ambient and cold chain conditions.

The certification covers the Agility-managed pharma storage facility at London’s Heathrow Airport and a second pharma competence centre in Bristol. The WDA(H) allows Agility  to provide a number of additional services, including pick-and-pack operations for the distribution of stored products to hospitals, pharmacies and other distributors, the re-packing into active and passive shipping configurations, and the distribution of clinical trial materials.

Colm McAlinden, Managing Director for Agility Area North West, said, “With this new certification, we are able to expand our Life Science service offerings in the UK and operate on behalf of our customers, particularly virtual wholesalers, brokers and importers. The certification also provides Agility with flexibility for post-Brexit import and export regulations.”

In the UK, Agility also provides logistics services to the aerospace, automotive, hi-tech, and retail industries. Agility offers more than 27,000 sqm of open and bonded warehouse space across 17 locations, including temperature-controlled storage. Agility’s combination of local service and global resources has helped it establish relationships spanning 15 to 20 years with many customers in the country.

About Agility
Agility brings efficiency to supply chains in some of the globe’s most challenging environments, offering unmatched personal service, a global footprint and customized capabilities in developed and developing economies alike. Agility is one of the world’s leading providers of integrated logistics. It is a publicly traded company with more than $4.6 billion in revenue and more than 22,000 employees in over 500 offices across 100 countries. Agility’s core commercial business, Global Integrated Logistics (GIL), provides supply chain solutions to meet traditional and complex customer needs. GIL offers air, ocean and road freight forwarding, warehousing, distribution, and specialized services in project logistics, fairs and events, and chemicals. Agility’s Infrastructure group of companies manages industrial real estate and offers logistics-related services, including e-government customs optimization and consulting, waste management and recycling, aviation and ground-handling services, support to governments and ministries of defense, remote infrastructure and life support. For more information about Agility, visit agility.com

Latest stories

Related stories

Integrated Inspection Systems for Leak Detection in Pharma

The pharmaceutical industry is increasingly moving toward a more holistic approach to quality control by combining various inspection technologies into a single, unified platform. Integrated inspection systems for leak detection in pharma offer a multi-faceted solution that simultaneously addresses cosmetic defects, particulate contamination, and container closure integrity. By merging high-speed visual cameras with sensitive high-voltage leak detection modules, these systems provide a comprehensive assessment of every unit, ensuring that each dose of medication is contained within a perfectly sealed and sterile environment. This integration not only reduces the risk of secondary contamination but also significantly improves the overall efficiency and reliability of the manufacturing process.

Advancing Pharma Quality with HV Leak Detection Tools

Maintaining the highest standards of pharmaceutical quality is a fundamental requirement for the safe delivery of injectable medications. The development of advancing pharma quality with HV leak detection tools represents a major leap forward in the deterministic testing of container closure integrity. By utilizing sophisticated sensors and high-voltage electrical fields, these tools can detect microscopic structural defects that would otherwise compromise the sterility of life-saving products. This high-sensitivity approach significantly enhances the accuracy of the inspection process, providing manufacturers with a robust solution for ensuring packaging integrity and regulatory compliance.

Sustainable Nutraceutical Ingredients Shaping the Future

The Shift Toward Sustainable Ingredients One of the most significant...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »